Mediwound Ltd Ord Sh (MDWD)

$15.05 -0.66 (-4.20%)
Market Cap 192.87M
Revenue (ttm) 16.96M
Net Income (ttm) -23.88M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -140.80%
Debt to Equity Ratio 0.00
Volume 123,200
Avg Vol 96,200
Day's Range N/A - N/A
Shares Out 12.82M
Stochastic %K 4%
Beta 0.13
Analysts Strong Sell
Price Target $31.33

Company Profile

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops EscharEx, a bromelain-based, bioactive enzymatic ther...

Industry: Biotechnology
Sector: Healthcare
Phone: 972 7 797 14100
Address:
42 Hayarkon Street, Yavne, Israel
_PeerlessSwings
_PeerlessSwings Mar. 28 at 11:03 PM
$CITR $MDWD $DVS $OSTX watchlist
0 · Reply
novelty
novelty Mar. 27 at 7:59 PM
$MDWD Ha Ha Ha Ha Ha
0 · Reply
novelty
novelty Mar. 27 at 3:19 PM
$MDWD complete breakdown targets 10$ and likely 9
0 · Reply
novelty
novelty Mar. 27 at 3:15 PM
$MDWD where are all the cocky bulls?
0 · Reply
novelty
novelty Mar. 27 at 2:45 PM
$MDWD 14’s today, 13’s next week, 10’s by end of month
0 · Reply
novelty
novelty Mar. 27 at 2:30 PM
$MDWD TOLD YOU
0 · Reply
novelty
novelty Mar. 27 at 2:08 PM
$MDWD 11$ incoming
0 · Reply
novelty
novelty Mar. 27 at 2:07 PM
$MDWD the Bidless warrior is a bottomless pit
0 · Reply
novelty
novelty Mar. 27 at 1:38 PM
$MDWD the Bidless warrior is hitting 14$$$$ who told u so? Bow down to the prophet
0 · Reply
novelty
novelty Mar. 27 at 1:35 PM
$MDWD 1$ a day probably another 7-10days before we hit 10$ and then bounce
0 · Reply
Latest News on MDWD
MediWound Ltd. (MDWD) Q4 2025 Earnings Call Transcript

Mar 5, 2026, 4:55 PM EST - 23 days ago

MediWound Ltd. (MDWD) Q4 2025 Earnings Call Transcript

MediWound Files Annual Report on Form 20-F

Mar 5, 2026, 4:30 PM EST - 23 days ago

MediWound Files Annual Report on Form 20-F

MediWound Reports Fourth Quarter and Full Year 2025 Financial Results

Mar 5, 2026, 7:00 AM EST - 23 days ago

MediWound Reports Fourth Quarter and Full Year 2025 Financial Results

MediWound to Report Fourth Quarter and Full Year 2025 Financial Results

Feb 19, 2026, 8:00 AM EST - 5 weeks ago

MediWound to Report Fourth Quarter and Full Year 2025 Financial Results

MediWound to Present at Upcoming Investor Conferences

Feb 17, 2026, 8:00 AM EST - 5 weeks ago

MediWound to Present at Upcoming Investor Conferences

MediWound Provides Corporate Update and Financial Outlook Ahead of the J.P. Morgan Healthcare Conference

Jan 12, 2026, 7:00 AM EST - 2 months ago

MediWound Provides Corporate Update and Financial Outlook Ahead of the J.P. Morgan Healthcare Conference

MediWound Reports New Clinical Data Demonstrating NexoBrid®'s Effectiveness in Preventing Traumatic Tattoos After Abrasion and Blast Injuries

Dec 10, 2025, 7:00 AM EST - 3 months ago

MediWound Reports New Clinical Data Demonstrating NexoBrid®'s Effectiveness in Preventing Traumatic Tattoos After Abrasion and Blast Injuries

MediWound Ltd. (MDWD) Q3 2025 Earnings Call Transcript

Nov 20, 2025, 10:43 AM EST - 4 months ago

MediWound Ltd. (MDWD) Q3 2025 Earnings Call Transcript

MediWound Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Nov 20, 2025, 7:00 AM EST - 4 months ago

MediWound Reports Third Quarter 2025 Financial Results and Provides Corporate Update

MediWound to Report Third Quarter 2025 Financial Results

Nov 5, 2025, 7:30 AM EST - 5 months ago

MediWound to Report Third Quarter 2025 Financial Results

MediWound Successfully Completes Commissioning of Expanded GMP Manufacturing Facility for NexoBrid®

Nov 3, 2025, 8:00 AM EST - 5 months ago

MediWound Successfully Completes Commissioning of Expanded GMP Manufacturing Facility for NexoBrid®

MediWound Announces $30 Million Registered Direct Offering of Ordinary Shares

Sep 29, 2025, 8:37 AM EDT - 6 months ago

MediWound Announces $30 Million Registered Direct Offering of Ordinary Shares

MediWound Expands Global Reach with Marketing Approval of NexoBrid® in Australia

Sep 25, 2025, 7:30 AM EDT - 6 months ago

MediWound Expands Global Reach with Marketing Approval of NexoBrid® in Australia

MediWound's NexoBrid® to be Highlighted in 36 Scientific Presentations at the 21st European Burns Association Congress

Sep 2, 2025, 7:30 AM EDT - 7 months ago

MediWound's NexoBrid® to be Highlighted in 36 Scientific Presentations at the 21st European Burns Association Congress

MediWound Is A Buy Opportunity On The Dip

Sep 2, 2025, 5:42 AM EDT - 7 months ago

MediWound Is A Buy Opportunity On The Dip

MediWound to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Aug 20, 2025, 7:30 AM EDT - 7 months ago

MediWound to Present at the H.C. Wainwright 27th Annual Global Investment Conference

MediWound Ltd. (MDWD) Q2 2025 Earnings Call Transcript

Aug 14, 2025, 1:31 PM EDT - 8 months ago

MediWound Ltd. (MDWD) Q2 2025 Earnings Call Transcript

MediWound Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Aug 14, 2025, 7:00 AM EDT - 8 months ago

MediWound Reports Second Quarter 2025 Financial Results and Provides Corporate Update

MediWound Announces New EscharEx® Phase II Data Demonstrating Strong Link Between Wound Bed Preparation and Wound Closure in Venous Leg Ulcers

Aug 13, 2025, 8:45 AM EDT - 8 months ago

MediWound Announces New EscharEx® Phase II Data Demonstrating Strong Link Between Wound Bed Preparation and Wound Closure in Venous Leg Ulcers

MediWound to Report Second Quarter 2025 Financial Results

Aug 4, 2025, 7:30 AM EDT - 8 months ago

MediWound to Report Second Quarter 2025 Financial Results

MediWound Ltd. (MDWD) Q1 2025 Earnings Call Transcript

May 21, 2025, 12:46 PM EDT - 11 months ago

MediWound Ltd. (MDWD) Q1 2025 Earnings Call Transcript

MediWound Reports First Quarter 2025 Financial Results and Provides Corporate Update

May 21, 2025, 7:00 AM EDT - 11 months ago

MediWound Reports First Quarter 2025 Financial Results and Provides Corporate Update

MediWound Ltd.: Undervalued High-Growth Potential

May 16, 2025, 10:34 AM EDT - 11 months ago

MediWound Ltd.: Undervalued High-Growth Potential

MediWound Announces Publication of Phase II EscharEx® Data Demonstrating Superiority Over Collagenase in Venous Leg Ulcers

May 13, 2025, 7:30 AM EDT - 11 months ago

MediWound Announces Publication of Phase II EscharEx® Data Demonstrating Superiority Over Collagenase in Venous Leg Ulcers

MediWound to Report First Quarter 2025 Financial Results

May 5, 2025, 8:00 AM EDT - 11 months ago

MediWound to Report First Quarter 2025 Financial Results

MediWound to Present New EscharEx® Data at Leading Wound Care Conferences

Apr 28, 2025, 8:00 AM EDT - 11 months ago

MediWound to Present New EscharEx® Data at Leading Wound Care Conferences

MediWound Ltd. (MDWD) Q4 2024 Earnings Call Transcript

Mar 19, 2025, 12:10 PM EDT - 1 year ago

MediWound Ltd. (MDWD) Q4 2024 Earnings Call Transcript

MediWound Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Mar 19, 2025, 7:00 AM EDT - 1 year ago

MediWound Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

MediWound to Report Fourth Quarter and Full Year 2024 Financial Results

Mar 3, 2025, 8:00 AM EST - 1 year ago

MediWound to Report Fourth Quarter and Full Year 2024 Financial Results

MediWound Announces Phase III CIDS Publication on NexoBrid® for Pediatric Burn Care

Feb 25, 2025, 8:00 AM EST - 1 year ago

MediWound Announces Phase III CIDS Publication on NexoBrid® for Pediatric Burn Care

MediWound to Present at the 45th Annual TD Cowen Health Care Conference

Feb 24, 2025, 8:00 AM EST - 1 year ago

MediWound to Present at the 45th Annual TD Cowen Health Care Conference

MediWound to launch Phase III trial for venous leg ulcers

Feb 12, 2025, 8:12 AM EST - 1 year ago

MediWound to launch Phase III trial for venous leg ulcers

MediWound Initiates the VALUE Global Phase III Pivotal Trial of EscharEx® for Treatment of Venous Leg Ulcers

Feb 12, 2025, 7:00 AM EST - 1 year ago

MediWound Initiates the VALUE Global Phase III Pivotal Trial of EscharEx® for Treatment of Venous Leg Ulcers

MediWound Ltd. (MDWD) Q3 2024 Earnings Call Transcript

Nov 26, 2024, 1:46 PM EST - 1 year ago

MediWound Ltd. (MDWD) Q3 2024 Earnings Call Transcript

MediWound Reports Third Quarter 2024 Financial Results and Provides Company Update

Nov 26, 2024, 7:00 AM EST - 1 year ago

MediWound Reports Third Quarter 2024 Financial Results and Provides Company Update

MediWound Is A Healthy Investment

Oct 29, 2024, 10:49 AM EDT - 1 year ago

MediWound Is A Healthy Investment

MediWound Announces Phase II Head-to-Head Study Evaluating EscharEx® vs. Collagenase in Patients with Venous Leg Ulcers

Oct 10, 2024, 7:00 AM EDT - 1 year ago

MediWound Announces Phase II Head-to-Head Study Evaluating EscharEx® vs. Collagenase in Patients with Venous Leg Ulcers

MediWound Announces U.S. Food and Drug Administration Approval of NexoBrid® for the Treatment of Pediatric Patients with Severe Thermal Burns

Aug 15, 2024, 4:15 PM EDT - 1 year ago

MediWound Announces U.S. Food and Drug Administration Approval of NexoBrid® for the Treatment of Pediatric Patients with Severe Thermal Burns

MediWound Ltd. (MDWD) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 3:00 PM EDT - 1 year ago

MediWound Ltd. (MDWD) Q2 2024 Earnings Call Transcript

MediWound Reports Second Quarter 2024 Financial Results and Provides Company Update

Aug 14, 2024, 7:00 AM EDT - 1 year ago

MediWound Reports Second Quarter 2024 Financial Results and Provides Company Update

MediWound Announces Positive Results from the U.S. NexoBrid® Expanded Access Protocol (NEXT)

Aug 5, 2024, 7:30 AM EDT - 1 year ago

MediWound Announces Positive Results from the U.S. NexoBrid® Expanded Access Protocol (NEXT)

MediWound to Report Second Quarter 2024 Financial Results

Aug 2, 2024, 8:00 AM EDT - 1 year ago

MediWound to Report Second Quarter 2024 Financial Results

MediWound Announces Publication of the EscharEx® Phase II ChronEx Study Results for Venous Leg Ulcers

Jul 29, 2024, 8:00 AM EDT - 1 year ago

MediWound Announces Publication of the EscharEx® Phase II ChronEx Study Results for Venous Leg Ulcers

MediWound Announces €16.25 Million Funding from the European Innovation Council Accelerator Program

Jul 16, 2024, 7:30 AM EDT - 1 year ago

MediWound Announces €16.25 Million Funding from the European Innovation Council Accelerator Program

Mölnlycke® Health Care announces US $15m investment in next-generation enzymatic therapeutics company MediWound Ltd

Jul 15, 2024, 7:32 AM EDT - 1 year ago

Mölnlycke® Health Care announces US $15m investment in next-generation enzymatic therapeutics company MediWound Ltd

MediWound Announces $25 Million Strategic Private Placement Financing

Jul 15, 2024, 7:00 AM EDT - 1 year ago

MediWound Announces $25 Million Strategic Private Placement Financing

MediWound Ltd. (MDWD) Q1 2024 Earnings Call Transcript

May 29, 2024, 11:35 AM EDT - 1 year ago

MediWound Ltd. (MDWD) Q1 2024 Earnings Call Transcript

MediWound Reports First Quarter 2024 Financial Results and Provides Company Update

May 29, 2024, 7:00 AM EDT - 1 year ago

MediWound Reports First Quarter 2024 Financial Results and Provides Company Update

MediWound to Report First Quarter 2024 Financial Results

May 22, 2024, 8:00 AM EDT - 2 years ago

MediWound to Report First Quarter 2024 Financial Results

MediWound to Present New Data from EscharEx® Phase II Studies at Three Leading Wound Care Conferences

Apr 25, 2024, 8:00 AM EDT - 2 years ago

MediWound to Present New Data from EscharEx® Phase II Studies at Three Leading Wound Care Conferences

_PeerlessSwings
_PeerlessSwings Mar. 28 at 11:03 PM
$CITR $MDWD $DVS $OSTX watchlist
0 · Reply
novelty
novelty Mar. 27 at 7:59 PM
$MDWD Ha Ha Ha Ha Ha
0 · Reply
novelty
novelty Mar. 27 at 3:19 PM
$MDWD complete breakdown targets 10$ and likely 9
0 · Reply
novelty
novelty Mar. 27 at 3:15 PM
$MDWD where are all the cocky bulls?
0 · Reply
novelty
novelty Mar. 27 at 2:45 PM
$MDWD 14’s today, 13’s next week, 10’s by end of month
0 · Reply
novelty
novelty Mar. 27 at 2:30 PM
$MDWD TOLD YOU
0 · Reply
novelty
novelty Mar. 27 at 2:08 PM
$MDWD 11$ incoming
0 · Reply
novelty
novelty Mar. 27 at 2:07 PM
$MDWD the Bidless warrior is a bottomless pit
0 · Reply
novelty
novelty Mar. 27 at 1:38 PM
$MDWD the Bidless warrior is hitting 14$$$$ who told u so? Bow down to the prophet
0 · Reply
novelty
novelty Mar. 27 at 1:35 PM
$MDWD 1$ a day probably another 7-10days before we hit 10$ and then bounce
0 · Reply
novelty
novelty Mar. 27 at 1:23 PM
$MDWD HOW are my HODLERS? Hahahaha
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 27 at 2:21 AM
$MDWD RSI: 35.71, MACD: -0.2750 Vol: 0.44, MA20: 17.05, MA50: 17.36 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
novelty
novelty Mar. 27 at 12:19 AM
$MDWD who is the greatest fortune teller of all? TOLD YA SO!
0 · Reply
novelty
novelty Mar. 26 at 9:41 PM
$MDWD 10% a day 10$ level comes quick
0 · Reply
novelty
novelty Mar. 26 at 6:26 PM
$MDWD 10$ stonk
0 · Reply
novelty
novelty Mar. 26 at 5:41 PM
$MDWD ha ha ha where’s all bulls gone?
0 · Reply
novelty
novelty Mar. 26 at 5:26 PM
$MDWD stock market crash takes this down 50% from here have fun boools
0 · Reply
novelty
novelty Mar. 26 at 5:21 PM
$MDWD BIDLESS warrior
0 · Reply
novelty
novelty Mar. 26 at 4:07 PM
$MDWD excited to buy everyone’s stop loss at 10$ even.
0 · Reply
novelty
novelty Mar. 26 at 3:27 PM
$MDWD look out below not a bid on this stock seen for miles. Hahahahaha 12$$$
0 · Reply
novelty
novelty Mar. 26 at 2:39 PM
$MDWD gone Bidless
0 · Reply
novelty
novelty Mar. 26 at 2:28 PM
$MDWD imagine bag holding this thinking it’s a winner. 😂
0 · Reply